Impact of 21‐Gene Breast Cancer Assay on Treatment Decision for Patients with T1–T3, N0–N1, Estrogen Receptor‐Positive/Human Epidermal Growth Receptor 2‐Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study

出版年份 2019 全文链接

标题

作者

关键词

出版物

ONCOLOGIST

Volume -, Issue -, Pages theoncologist.2019-0103

出版商

Alphamed Press

发表日期

2019-06-01

DOI

10.1634/theoncologist.2019-0103

向作者/读者发起求助以获取更多资源

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

ONCOLOGIST

向作者/读者发起求助以获取更多资源

Protocol

Reagent

Reprint

Publish scientific posters with Peeref

Find the ideal target journal for your manuscript